News

PredictImmune exhibiting and presenting poster at the Crohn’s & Colitis Congress® in Las Vegas

Cambridge, UK, 17th January 2019:  A great opportunity has arisen to meet PredictImmune’s VP of Platform Discovery, Dr Paul Lyons, and discuss the latest data on its new prognostic biomarker test, PredictSURE IBD™. Both Dr Lyons and Dr Karen Hills will be on booth #1406 of the Crohn’s and Colitis Foundation Congress, Bellagio Conference Centre, Las Vegas, Feb 7th through 9th. Join them to hear the latest developments and discuss availability of the test in the US.

Crohn’s and Colitis Congress, February 7-9th 2019

Venue: Bellagio Conference Centre, Las Vegas, NV

The congress, the premier US conference on IBD, offers a great opportunity to gain a multidisciplinary perspective on treating inflammatory bowel diseases (IBD).  The congress will allow you to mix with fellow healthcare professionals and researchers, discover the latest research, and gain different perspectives on IBD treatment. Furthermore, it’s an excellent opportunity to hear about ground-breaking developments such as the PredictSURE IBD™ prognostic test.

Poster presentation

A blood-based prognostic biomarker in inflammatory bowel disease; towards personalised medicine in IBD

Session:  Diagnostics in IBD:  Thursday, Feb. 7th , 7:15 – 8:30 p.m. and Friday, Feb. 8th , 3:50 – 4:20 p.m. In the Grand Ballroom, Bellagio Conference Centre

Presentation Number: P028

Follow

Follow the congress, on Twitter, using the hashtag: #CCCongress

Future exhibitions 

PredictImmune will also attend the following events in the next few months:

We hope to meet you all there!